Abstract

This paper summarizes recent synthetic efforts devoted to the generation of new, second-generation texaphyrin-type drugs, specifically species that involve known or potential anticancer agents covalently attached to a tumor-localizing texaphyrin core. Particular emphasis will be placed on the strategies needed to prepare such systems, as well as on the choice of active group being subject to attachment.

Document Type

Article

DOI

https://doi.org/10.1351/pac200476020365

Rights Information

© 2004 IUPAC

Publication Date

2004

Journal Title

Pure and Applied Chemistry

Download

Share

COinS